In particular, it is known that in diabetic patients, there is an increased renal production of TGF-β that is a potent modulator of extracellular matrix (ECM) proteoglycan synthesis and represents a potential link between hyperglycaemia and the accelerated development of atherosclerosis in diabetes [54]. This evidence concerns the gene TGFB1 and atherosclerosis.